Thomas Dubensky Insider Profile
4 Followers
Thomas Dubensky, President, Director at Tempest Therapeutics, holds 113.34K shares in Tempest Therapeutics (Ticker: TPST), holds 0.00 shares in Chinook Therapeutics (Ticker: KDNY), holds ― shares in HTG Molecular Diagnostics (Ticker: HTGMQ). Most recently, Thomas Dubensky Bought ― shares of Tempest Therapeutics on Jan 11, 2022 for an estimated value of $9.56K.
Thomas Dubensky's Trading History
You May Also Like
Thomas Dubensky insider profile FAQ
What stocks does Thomas Dubensky hold?
Thomas Dubensky holds: TPST, KDNY, HTGMQ stocks.
What was Thomas Dubensky’s latest transaction?
Thomas Dubensky’s latest transaction was an Informative Buy of $9.56K.
What is Thomas Dubensky's role in Tempest Therapeutics?
Thomas Dubensky's role in Tempest Therapeutics is President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
